ConsultantBiomX IncFrederick, Maryland, United States
Disclosure information not submitted.
234 - Phage Therapy with BX211 Demonstrates Positive Efficacy Results in Staphylococcus Aureus Diabetic Foot Osteomyelitis: Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Monday, October 20, 20254:03 PM - 4:15 PM US ET